Yi Lu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yi Lu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Chun Chen
Fujian Key Laboratory of Neonatal Diseases, Xiamen Key Laboratory of Neonatal Diseases, Xiamen Childreǹs Hospital (Children’s Hospital of Fudan University at Xiamen), Xiamen 361006, China
1 shared publicationDeyi Zhuang
Fujian Key Laboratory of Neonatal Diseases, Xiamen Key Laboratory of Neonatal Diseases, Xiamen Childreǹs Hospital (Children’s Hospital of Fudan University at Xiamen), Xiamen 361006, China
1 shared publicationFengge Ma
From the State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Fujian 361005, China
1 shared publication- Fengning Liu
Center for Multidimensional Carbon Materials Institute for Basic Science Ulsan 44919 Republic of Korea
1 shared publication - Liling Qian
Division of Pulmonary Medicine, Shanghai Children's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
1 shared publication - Pan Feng
School of Materials Science and Engineering, Southeast University, Nanjing 211189, China
1 shared publication
Latest Publications
- Open Access
- 1 May 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (19) , 20957-20965
Molecular Dynamic Simulation To Reveal the Mechanism Underlying MGL-3196 Resistance to Thyroxine Receptor Beta
Thyroxine receptor beta (TRβ) is a ligand-dependent nuclear receptor that participates in regulating multiple biological processes, particularly playing an important role in lipid metabolism regulation. TRβ is currently a popular therapeutic target for nonalcoholic steatohepatitis (NASH), while no drugs have been approved to treat this disease. MGL-3196 (Resmetirom) is the first TRβ agonist that has succeeded in phase III clinical trials for the treatment of NASH; therefore, studying its molecular mechanism of action is of great significance. In this study, we employed molecular dynamic simulation to investigate the interaction mode between MGL-3196 and TRβ at the all-atom level. More importantly, by comparing the binding patterns of MGL-3196 in several prevalent TRβ mutants, it was identified that the mutations R243Q and H435R located, respectively, around and within the ligand-binding pocket of TRβ cause TRβ to be insensitive to MGL-3196. This indicates that patients with NASH carrying these two mutations may exhibit resistance to the medication of MGL-3196, thereby highlighting the potential impact of TRβ mutations on TRβ-targeted treatment of NASH and beyond.
- 1 May 2024
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 9 (19) , 20957-20965
Open AccessMolecular Dynamic Simulation To Reveal the Mechanism Underlying MGL-3196 Resistance to Thyroxine Receptor Beta
Thyroxine receptor beta (TRβ) is a ligand-dependent nuclear receptor that participates in regulating multiple biological processes, particularly playing an important role in lipid metabolism regulation. TRβ is currently a popular therapeutic target for nonalcoholic steatohepatitis (NASH), while no drugs have been approved to treat this disease. MGL-3196 (Resmetirom) is the first TRβ agonist that has succeeded in phase III clinical trials for the treatment of NASH; therefore, studying its molecular mechanism of action is of great significance. In this study, we employed molecular dynamic simulation to investigate the interaction mode between MGL-3196 and TRβ at the all-atom level. More importantly, by comparing the binding patterns of MGL-3196 in several prevalent TRβ mutants, it was identified that the mutations R243Q and H435R located, respectively, around and within the ligand-binding pocket of TRβ cause TRβ to be insensitive to MGL-3196. This indicates that patients with NASH carrying these two mutations may exhibit resistance to the medication of MGL-3196, thereby highlighting the potential impact of TRβ mutations on TRβ-targeted treatment of NASH and beyond.
- 7 March 2020
- Published by Wiley in The Structural Design of Tall and Special Buildings
- Vol. 29 (9)
An estimate on in‐construction differential settlement of super high‐rise frame core–tube buildings
SUMMARY: To physically identify the mechanisms behind the development of in‐construction settlement of super high‐rise frame core–tube buildings, a simplified approach is developed by the full understanding about the typical structural layouts, specific construction feature, and load transfer path of those buildings as well as time‐dependent effects. With the reference to several typical structural layouts, a simplified one‐bay multistory model is developed that consists of two overall vertical components and horizontal components representing the exterior columns, core tubes, and beams (or mega trusses), respectively, in those super high‐rise buildings. Based on this model, a simplified approach with a so‐called “global–local” strategy is proposed to account for the difference in the settlement of the corner columns and side columns. The leading construction and final screwing at the rigid connections between beams (or trusses) and exterior columns, which are commonly implemented during the construction of those buildings, are seriously addressed in the simplified approach, as well as strengthened floors and time‐dependent effects. The applicability and accuracy of the proposed approach is demonstrated by a 128‐story 606‐m‐level super high‐rise frame core–tube building. The proposed simplified approach can be helpful for the development of preliminary construction schemes and the control strategy for differential settlement.
- 7 March 2020
- Published by Wiley in The Structural Design of Tall and Special Buildings
- Vol. 29 (9)
An estimate on in‐construction differential settlement of super high‐rise frame core–tube buildings
SUMMARY: To physically identify the mechanisms behind the development of in‐construction settlement of super high‐rise frame core–tube buildings, a simplified approach is developed by the full understanding about the typical structural layouts, specific construction feature, and load transfer path of those buildings as well as time‐dependent effects. With the reference to several typical structural layouts, a simplified one‐bay multistory model is developed that consists of two overall vertical components and horizontal components representing the exterior columns, core tubes, and beams (or mega trusses), respectively, in those super high‐rise buildings. Based on this model, a simplified approach with a so‐called “global–local” strategy is proposed to account for the difference in the settlement of the corner columns and side columns. The leading construction and final screwing at the rigid connections between beams (or trusses) and exterior columns, which are commonly implemented during the construction of those buildings, are seriously addressed in the simplified approach, as well as strengthened floors and time‐dependent effects. The applicability and accuracy of the proposed approach is demonstrated by a 128‐story 606‐m‐level super high‐rise frame core–tube building. The proposed simplified approach can be helpful for the development of preliminary construction schemes and the control strategy for differential settlement.
- Open Access
- 1 August 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (32) , 12535-12541
Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR
- 1 August 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (32) , 12535-12541
Open AccessStructural insights into the heterodimeric complex of the nuclear receptors FXR and RXR